NU100: Completed Phase III enrollment

Nuron completed enrollment of 500 RRMS patients in a double-blind, placebo-controlled, European Phase III trial comparing NU100 vs. Betaferon interferon beta-1b. Nuron has exclusive, worldwide rights...